CIM Investment Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $282K | Buy |
61,117
+30,671
| +101% | +$142K | 0.05% | 217 |
|
2025
Q1 | $101K | Sell |
30,446
-726
| -2% | -$2.42K | 0.02% | 230 |
|
2024
Q4 | $231K | Hold |
31,172
| – | – | 0.07% | 214 |
|
2024
Q3 | $293K | Hold |
31,172
| – | – | 0.09% | 190 |
|
2024
Q2 | $250K | Buy |
31,172
+17,399
| +126% | +$140K | 0.08% | 200 |
|
2024
Q1 | $204K | Hold |
13,773
| – | – | 0.06% | 255 |
|
2023
Q4 | $112K | Hold |
13,773
| – | – | 0.04% | 277 |
|
2023
Q3 | $62.7K | Hold |
13,773
| – | – | 0.02% | 273 |
|
2023
Q2 | $97K | Hold |
13,773
| – | – | 0.03% | 269 |
|
2023
Q1 | $84.2K | Buy |
13,773
+476
| +4% | +$2.91K | 0.03% | 257 |
|
2022
Q4 | $85K | Buy |
+13,297
| New | +$85K | 0.03% | 237 |
|